Got $5,000? Get the Most Bang for Your Buck With These 4%-Plus Dividend Yield StocksThe Motley Fool • 11/10/23
Why this Dow stock went from worst in 2022 to first in 2023 — and 13 turnaround candidates for 2024Market Watch • 11/09/23
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare ConferenceGlobeNewsWire • 11/07/23
Sosei Heptares' Partner, Pfizer, Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 TrialGlobeNewsWire • 11/05/23
Seeking High Dividends? 3 Fairly Valued/Undervalued High Dividend Yield Stocks For Your PortfolioSeeking Alpha • 11/04/23
Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual MeetingBusiness Wire • 11/02/23
3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 MonthsThe Motley Fool • 11/02/23